Zusammenfassung
Einer der Unterschiede in der Zusammensetzung von Muttermilch und künstlichen Säuglingsnahrungen auf Kuhmilchbasis besteht im Gehalt an langkettigen mehrfach ungesättigten Fettsäuren („long chain polyunsaturated fatty acids“, LCPUFA). Die Zugabe von Nervon-, Docosapentaen- und Docosahexaensäure zu Formulamilchen wurde empfohlen (Sala-Vila et al. 2004) und inzwischen teilweise von den Herstellern umgesetzt, obwohl auch festgestellt wurde, dass dies keinen Vorteil erbringt, wenn bereits 10 % der Energie als Linolensäure und 1 % als α-Linolensäure zugeführt werden (Auestad et al. 2004).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Agostoni C, Verduci E, Massetto N et al. (2003) Plasma long-chain polyunsaturated fatty acids and neurodevelopment through the first 12 months of life in phenylketonuria. Develop Med Child Neurol 45: 257–261
Agostoni C, Braegger C, Decsi T et al. (2011) Supplementation of N-3 LCPUFA to the diet of children older than 2 years: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr. 53(1): 2–10
Antalis CJ, Stevens LJ, Campbell M et al. (2006) Omega-3 fatty acid status in attention-deficit/hyperactivity disorder. Prostaglandins Leukotrienes Essential Fatty Acids 75: 299–308
Auestad N, Halter R, Hall RT et al. (2004) Growth and development in term infants fed long-chain polyunsaturated fatty acids: a double-masked, randomized, parallel, prospective, multivariate study. Pediatrics 108(2): 372–381
Cleary MA, Feillet F, White FJ et al. (2006) Randomised controlled trial of essential fatty acid supplementation in phenylketonuria. Eur J Clin Nutr 60: 915–920
Colombo C, Bennato V, Costantini D et al. (2006) Dietary and circulating polyunsaturated fatty acids in cystic fibrosis: Are they related to clinical outcomes? JPGN 43: 660–665
Crooke RM, Graham MJ, Lemonidis KM et al. (2005) An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis. J Lipid Res 46: 872–884
Durrington PN, Bhatnagar D, Mackness MI et al. (2001) An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia. Heart 85(5): 544–548
Fell JME, Paintin M, Arnaud-Battandier F et al. (2000) Mucosal healing and a fall in mucosal proinflammatory cytokine mRNA induced by a specific oral polymeric diet in pediatric Crohn’s disease. Aliment Pharmacol Ther 14: 281–289
Gassull MA, Cabre E (2001) Nutrition in inflammatory bowel disease. Curr Opin Clin Nutrition Metab Care 4: 561–569
Hadders-Algra M, Bouwstra H, Goor SA van et al. (2007) Prenatal and early postnatal fatty acid status and neurodevelopmental outcome. J Perinat Med 35: S28–S34
Joshi K, Lad S, Kale M et al. (2006) Supplementation with flax oil and vitamin C improves the outcome of Attention Deficit Hyperactivity Disorder (ADHD). Prostaglandins Leukotrienes Essential Fatty Acids 74: 17–21
Jürgens K, Kraft J, Jahreis G (2007) Ernährung von Patienten mit Adrenoleukodystrophie und Adrenomyeloneuropathie. Ernährungsumschau 4: 188–193
Kalivianakis M, Minich DM, Bijleveld CMA et al. (1999) Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids. Am J Clin Nutr 69: 127–134
Martínez M, Vázquez E, García-Silva MT et al. (2000) Therapeutic effects of docosahexaenoic acid ethyl ester in patients with generalized peroxisomal disorders. Am J Clin Nutr 71: 376S–385S
Miyazawa R, Tomomasa T, Kaneko H et al. (2006) Effect of formula thickened with locust bean gum on gastric emptying in infants. J Paediatr Child Health 42: 808–812
Moser AB, Jones DS, Raymond GV et al. (1999) Plasma and red blood cell fatty acids in peroxisomal disorders. Neurochem Res 24 (2): 187–197
Paker AM et al (2010) Docosahexaenoic acid therapy in peroxisomal diseases: results of a double-blind, randomized trial.Neurology 75(9): 826–830
Sala-Vila A, Castellote AI, Campoy C et al. (2004) The source of long-chain PUFA in formula supplements does not affect the fatty acid composition of plasma lipids in full-term infants. J Nutr 134: 868–873
Simmer K, Patole SK, Rao SC (2008) Longchain polyunsaturated fatty acid supplementation in infants born at term.Cochrane Database Syst Rev 1: CD000376
Socha P, Ryzko J, Koletzko B et al. (2005) Essential fatty acid depletion in children with inflammatory bowel disease. Scand J Gastroenterol 40: 573–577
Vandenplas Y, Belli D, Benhamou PH et al. (1996) Current concepts and issues in the management of regurgitation of infants: A reappraisal. Acta Paediatr 85: 531–534
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Krawinkel, M.B. (2013). Supplementierung inklusive therapeutische Formelnahrung. In: Rodeck, B., Zimmer, KP. (eds) Pädiatrische Gastroenterologie, Hepatologie und Ernährung. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-24710-1_29
Download citation
DOI: https://doi.org/10.1007/978-3-642-24710-1_29
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-24709-5
Online ISBN: 978-3-642-24710-1
eBook Packages: Medicine (German Language)